Post herpetic neuralgia: A review

Irish Journal of Medical Science

Volumn 167, Issue 2, 1998, Pages 74-78

  Griffin, M J ^a   Chambers, F A ^a   MacSullivan, R ^a  

^a MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ACICLOVIR; AMITRIPTYLINE; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; CAPSAICIN; CHLOROETHANE; FAMCICLOVIR; KETAMINE; LIDOCAINE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; STEROID; TRAMADOL; VALACICLOVIR;

BURN; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DERMATITIS HERPETIFORMIS; EPIDURAL ANESTHESIA; ERYTHEMA; FATIGUE; HERPES ZOSTER; HERPES ZOSTER OPHTHALMICUS; HUMAN; IMMUNOTHERAPY; INTRAVENOUS DRUG ADMINISTRATION; META ANALYSIS; NAUSEA; ORAL DRUG ADMINISTRATION; POSTHERPETIC NEURALGIA; PRURITUS; RANDOMIZED CONTROLLED TRIAL; REVIEW; SUBCUTANEOUS DRUG ADMINISTRATION; TOPICAL DRUG ADMINISTRATION; VERTIGO;

EID: 0031750159     PISSN: 00211265     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02937940     Document Type: Review

References (67)

1. Ragozzino, M. W. Population-based study of herpes zoster and its sequelae. Medicine 1982; 61: 310.
2. Burgoon, C. F., Burgoon, J. S., Baldridge, G. D. The natural history of herpes zoster. JAMA 1957; 164: 265.
3. Watson, C. P., Deck, J. H., Morshead, C., Van der Kooy, D., Evans, R. J. Post-herpetic neuralgia: further postmortem studies of cases with and without pain. Pain 1991; 44: 105-117.
4. Noordenbos, W. Pain. Edition 1. Amsterdam, Elsevier, 195; pp. 1-182.
5. Zacks, S. I., Langfitt, T. W., Elliot, FA. Herpetic neuritis. A light and electron microscopic study. Neurology 1964; 14: 744.
6. Coderre, T. J., Katz, J., Vaccarino, A. L., Melzak, R. Contribution of central neuroplasticity to pathological pain: review of clinical and experimental evidence. Pain 1993; 52: 259-285.
7. Willis, W. D. Central Plastic Responses to pain. Proceedings Seventh World Pain CONRESS - Progress in Pain, Research and Management. Eds. Gevhart, G. F., Hammond, D. L., Genson, T. S. Vol. 2, IASP Press, Seattle 1994.
8. Woolf, C. J., Thompson, S. W. The induction and maintenance of central sensitization is dependent on N-methyl-D-aspartic acid receptor activation, implications for the treatment of post-injury pain hypersensitivity states. Pain 1991; 44: 293-299.
9. Ragozzino, M. W., Melton, L. J., Kurland, L. T. Population-based study of herpes zoster and its sequelae. Medicine 1982; 61: 310-316.
10. Balfour, H. H. Acyclovir halts progression of herpes zoster in immunocompromised patients. N. Engl. J. Med. 1983; 308: 1448.
11. Bean, B., Aeppli, D., Balfour, H. H. Acyclovir in shingles. J. Antimicrob. Chemother. 1983; 12(Suppl. B): 123.
12. Huff, J. C., Drucker, J. L., Clemmer, A., Laskin, O. L., Connor, J. D., Bryson, Y. J., Balfour, H. H. Effect of oral acyclovir on pain resolution in herpes zoster: a reanalysis. J. Med. Virol. 1993; Suppl 1: 93-6.
13. Lancaster, T., Silagy, C., Gray, S. Primary care management of acute herpes zoster: systemaic review of evidence from randomized controlled trials. Br. J. Gen. Pract. 1995; 45(390): 39-45.
14. Crooks, R. J., Jones, D. A., Fiddian, A. P. Zoster-associated chronic pain: an overview of clinical trials with acyclovir. Scand. J. Infect. Dis. 1991; Suppl. 78: 62-68.
15. Bowsher, D. Acute herpes zoster and postherpetic neuralgia: effects of acyclovir and outcome of treatment with amitriptyline. Br. J. Gen. Pract. 1992; 42(3 59): 244-6.
16. Balfour, H. H. Intravenous acyclovir for acute herpes zoster: a double-blind controlled trial. J. Infect. 1983; 6 (suppl): 31-6.
17. Jacobson, M. A. Valaciclovir (BW256U87): the L-valyl ester of acyclovir. J. Med. Virol. 1993; Suppl. 1: 150-153.
18. Tyring, S., Barbarash, R. A., Nahlik, J. E., Cunningham, A., Marley, J., Heng, M., Jones, T., Rea, T., Boon, R., Saltzman, R. Famciclovir for the treatment of acute herpes zoster: effects on acute disease and postherpetic neuralgia. A randomized, double-blind, placebo-controlled trial. Collaborative Famciclovir Herpes Zoster Study Group. Ann. Intern. Med. 1995; 123(2): 89-96.
19. Sklar, S. H., Blue, W. T., Alexander, E. J., Bodian, C. A. Herpes zoster. The treatment and prevention of neuralgia with adenosine monophosphate. JAMA 1985; 253: 1472.
20. Galbraith, A. W. Prevention of post-herpetic neuralgia by amantadine hydrochloride (Symmetrel). Br. J. Clin. Pract. 1983; 37: 304.
21. Eaglestein, W. H., Katz, R., Brown, J. A. The effects of early corticosteroid therapy on the skin eruption and pain of herpes zoster. JAMA 1970; 211: 1681.
22. Benoldi, D., Mirizzi, S., Zucchi, A., Allegra, F. Prevention of postherpetic neuralgia. Evaluation of treatment with oral prednisone, oral acyclovir and radiotherapy. Inter J. Dermatol. 1991; 30(4): 288-90.
23. Keczkes, K., Basheer, A. M. Do corticosteroids prevent post-herpetic neuralgia? Br. J. Dermatol. 1980; 102: 551.
24. Calza, A. M., Schmied, E., Harms, M. Systemic corticosteroids do not prevent postherpetic neuralgia. Dermatology 1992; 184(4): 314-6.
25. Wood, M. J., Johnson, R. W., McKendrick, M. W., Taylor, J., Mandai, B. K., Crooks, J. A randomized trial of acyclovir for 7 days or 21 days with and without prednisolone for treatment of acute herpes zoster. N. Engl. J. Med. 1994; 330: 896-900.
26. Epstein, E. Corticosteroid therapy of zoster: Oral vs sublesional injection. Hawaii Med. J. 1982; 41: 420.
27. King, R. B. Topical aspirin in chloroform and the relief of pain due to herpes zoster and postherpetic neuralgia. Arch. Neurol. 1993; 50(10): 1046-53.
28. De Benedittis, G., Besana, F., Lorenzetti, A. A new topical treatment for acute herpetic neuralgia and postherpetic neuralgia: the aspirin/diethyl ether mixture. An open-label study plus a double-blind controlled clinical trial. Pain 1992; 48(3): 383-90.
29. Max, M. B. Treatment of post-herpetic neuralgia: antidepressants. Ann. Neurol. 1994; 35 (Suppl): S50-3.
30. Rowbotham, M. C. Treatment of postherpetic neuralgia. Seminars in Dermatology 1992; 3: 218-25.
31. Watson, C. P., Chipman, M., Reed, K., Evans, R. J., Birkett, N. Amitriptyline versus maprotiline in postherpetic neuralgia: a randomized, double-blind, crossover trial. Pain 1992; 48(1): 29-36.
32. Watson, C. P. Therapeutic window for amitriptyline analgesia. Can. Med. Assoc. J. 1984; 130: 105.
33. Weis, O., Sriwatanakul, K., Weintraub, M. Treatment of post-herpetic neuralgia and acute herpetic pain with amitriptyline and perphenazine. S. A. Med. J. 1982; 62: 274.
34. Gerson G. R., Jones, R. B., Luscombe, D. K. Studies on the concomitant use of carbamazepine and clomipraimne for the relief of post-herpetic neuralgia. Postgrad. Med. J. 1977; 53 (Suppl 4): 104.
35. Hatangdi, V. S., Boas, R. A., Richards, E. G. Postherpetic neuralgia: Management with antiepileptic and tricyclic drugs. Advances in Pain Research and Therapy. Vol. 1 .Eds. J. J. Bonica, D. Albe-Fessard. New York, Raven Press, 1976, pp. 583-587.
36. Killian J. M., Fromm, G. H. Carbamazepine in the treatment of neuralgia. Use and side effects. Arch. Neurol. 1968; 19:129.
37. Rafferty, A. The management of postherpetic pain using sodium valproate and amitriptyline. Ir. Med. J. 1972, 72: 399.
38. Eide K., Stubhaug, A., Oye, I., Breivik, H. Continuous Subcutaneous administration of the N-methyl-D-aspartic acid (NMDA) receptor antagonist ketamine in the treatment of post-herpetic neuralgia. Pain 1995; 62 (2): 221-8.
39. Eide, P. K., Jorum, E., Stubhaug, A., Bremnes J., Breivik, H. Relief of post-herpetic neuralgia with the N-methy-D-aspartic acid receptor antagonist ketamine: a double-blind cross-over comparison with morphine and placebo. Pain 1994; 58(3): 347-54.
40. Hoffmann, V., Coppejans, H., Vercauteren. M. Adriaensen, H. Successful treatment of postherpetic neuralgia with oral ketamine. Clin. J. Pain 1994; 10(3): 240-2.
41. Sokolowski, P. Capsaicin in pain therapy. Wiadomosci Lekarskie 1994; 47(13-14): 527-32.
42. Peikert A., Hentrich, M., Ochs, G. Topical 0.025% capsaicin in chronic post-herpetic neuralgia efficacy, predictors of response and long-term course. J. Neurol. 1991; 238(8): 452-6.
43. Watson, C. P., Tyler, K. L., Bickers, D. R., Millikan, L. E., Smith, S., Coleman, E. A randomized vehicle-controlled trial of topical capsaicin in the treatment of postherpetic neuralgia. Clin. Ther. 1993; 15: 510-526.
44. Rowbotham, M. C., Davies, P. S., Fields, H. L. Topical lidocaine gel relieves postherpetic neuralgia. Annals. Neurol. 1995; 37(2): 246-53.
45. Rosenak, S. Procaine injection treatment of herpes zoster. Lancet 1938; 2: 1056.
46. Colding, A. The effect of regional sympathetic blocks in the treatment of herpes zoster. Acta Anaesth. Scand. 1969, 13: 133.
47. Colding, A. Treatment of pain: Organization of a pain clinic: Treatment of acute herpes zoster. Proc. R. Soc. Med. 1973; 66: 541.
48. Winnie, A. P., Hartwell, P. W. Relationship between time of treatment of acute herpes zoster with sympathetic blockade and prevention of post-herpetic neuralgia: clinical support for a new theory of the mechanism by which sympathetic blockade provides therapeutic benefit. Regional Anaesth. 1993; 18: 277-282.
49. Riopelle, J. M., Naraghi, M., Grush, K. P. Chronic neuralgia incidence following local anaesthetic therapy for herpes zoster. Arch. Dermatol. 1984; 120:747.
50. Morimoto, M., Morimoto, E., Okabayashi, K., Morimoto, M. Hyodo, M. Use of a disposable infusion device for continous epidural block. Masui, 43(9): 1336-1340.
51. Shanbrom, E. Treatment of herpetic pain and postherpetic neuralgia with intravenous procame. JAMA 1961; 170: 1041.
52. Barnard, D., Lloyd, J., Evans, J. Cryoanalgesia in the management of chronic facia pain. J. Maxillofac. Surg. 1981; 9: 101.
53. Suzuki, H. Cryotherapy of sensitized skin areas for the relief of pain due to post-herpetic neuralgia. Pain 1980; 9: 355.
54. White, J. C., Sweet, W. H. Pain and the Neurosurgeon Springfield, IL, Charles C. Thomas, 1969; Edition 1, 382-384.
55. Friedman, A. H., Nashold, B. S. Dorsal root entry zone lesions for the treatment of postherpetic neuralgia. Neurosurgery 1984; 15: 969.
56. Friedman, A. H., Nashold, B. S., Ovelmen-Levitt, J. Dorsal root entry zone lesions for the treatment of postherpetic neuralgia. J. Neurosurg. 1984; 60: 1258.
57. Siegfried. J. Monopolar electrical stimulation of nucleus ventroposteromedialis thalami for postherpetic facial pain. Appl. Neurophysiol. 1982; 45: 179.
58. Young, R. F., Rinaldi, P. C. Brain stimulation for relief of chronic pain. Eds. Wall, P. D., Melzack R. Textbook of Pain. Churchill Livingstone, Edinburgh: 1225-1233.
59. Young, R. F., Jacques, D. S., Rand, R. W., Coocutt B. R. Medial thalamotomy with the Leksell Gamma knife for treatment of chronic pain. Acta Neurochir. Suppl. Wien. 1994; 62: 105-110
60. Hugler, P., Heimann, R., Laubenthal, H. Therapy of postherpetic neuralgia. Pain therapy using an anti-varicella zoster immunoglobulin. Anaesthesist 1992; 41(12): 772-8.
61. Ikebe, H. Miyagawa, A., Mizutani, A., Miyamoto, M., Taniguchi, K., Honda, N. The effect of iontophoresis with several Ca channel blockers for PHN patients. Japan J. Anesth. 1995; 44(3): 428-33.
62. Saiki M., Kondo, A., Kinuta, Y., Iwasaki, K., Kobata, H., Hasegawa, K., Chin, M., Nakano, I., Yamanioto, T. Treatment of intractable postherpetic neuralgia and blepharospasm: intraneural injection of adriamycin. No Shinkei Geka - Neurological Surgery 1995; 23(2): 125-30.
63. Pappagallo, M., Campbell, J. N. Chronic opioid therapy as an alternative treatment for postherpetic neuralgia. Ann. Neurol. 1994; 35 Suppl: S54-6.
64. Rowbotham, M. C. Managing postherpetic neuralgia with opioids and local anaesthetics. Ann. Neurol. 1994, 35 Suppl: S46-9.
65. Rogers, K. A., Tramadol. Br. J. Anaesthesia 1995; 74(3): 1-2.
66. Lewith, G. T., Field, J., Machin, D. Acupuncture compared with placebo in post-herpetic pain. Pain 1983, 17; 361.
67. Haas, L. F. Post-herpetic neuralgia, treatment and prevention. Trans. Ophthalmol. Soc. N.Z. 1977; 29: 133.